Inactive Instrument

Press Releases Medivation Inc

Equities

US58501N1019

End-of-day quote Nasdaq Other stock markets
- ^USD	-

2016	Eli Lilly and : Drugmaker Sanofi hungry for deals after earnings beat	RE
2016	Exclusive - GW Pharmaceuticals hires investment bank following approaches: sources	RE

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Medivation : New Data Presented at ESMO 2016 Further Demonstrates XTANDITM▼ (enzalutamide) Significantly Improves Time to PSA Progression in Advanced Prostate Cancer, Compared with Placebo	16-10-09	BU
Brower Piven Commences An Investigation Into The Proposed Sale Of Medivation, Inc. And Encourages Shareholders To Contact The Firm For Additional Information	16-08-25	BU
Brower Piven Commences An Investigation Into The Proposed Sale Of Medivation, Inc. And Encourages Investors To Contact The Firm For Additional Information	16-08-22	BU
REMINDER: Medivation to Host Conference Call and Webcast Providing Detailed Review of Talazoparib on July 6, 2016	16-07-06	BU
Medivation : Enters into Confidentiality Agreements, Including with Sanofi	16-07-05	BU
Medivation : Glass Lewis Recommends Medivation's Stockholders Support the Company's Current Board	16-06-24	PU
Medivation : Glass Lewis Recommends Medivation’s Stockholders Support the Company’s Current Board	16-06-24	BU
Medivation : Sends Letter to Stockholders to Set the Record Straight on Sanofi's Misleading Claims	16-06-23	PU
Medivation : Sends Letter to Stockholders to Set the Record Straight on Sanofi’s Misleading Claims	16-06-23	BU
Medivation : Files Definitive Consent Revocation Statement and Mails Letter to Stockholders	16-06-13	BU
Medivation : Sets Record Date for Sanofi's Proposed Consent Solicitation	16-06-01	PU
Medivation : Sets Record Date for Sanofi’s Proposed Consent Solicitation	16-06-01	BU
Medivation : Files Preliminary Consent Revocation Statement	16-05-27	BU
Medivation : Urges Stockholders to Reject Sanofi's Attempt to Replace Medivation Board of Directors	16-05-25	PU
Medivation : Urges Stockholders to Reject Sanofi’s Attempt to Replace Medivation Board of Directors	16-05-25	BU
Medivation : Reiterates Rejection of Sanofi's Substantially Inadequate Proposal	16-05-05	BU
Medivation : CHMP Issues Positive Opinion to Include New Data in European Label for XTANDI(R) (enzalutamide)	16-04-07	PR
Medivation : Jennifer Jarrett to Join Medivation as Chief Financial Officer	16-03-28	MW
Medivation : Pivotal Phase III Trial of Enzalutamide Initiated in Metastatic Hormone Sensitive Prostate Cancer	16-03-24	MW
Medivation : U.S. FDA Lifts Partial Clinical Hold on Medivation's Pidilizumab	16-03-09	MW

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Medivation Inc

Equities

US58501N1019

Press Releases

Filters